101 related articles for article (PubMed ID: 11893651)
1. Oligonucleotide microarray analysis of lung adenocarcinoma in smokers and nonsmokers identifies GPC3 as a potential lung tumor suppressor.
Powell CA; Xu G; Filmus J; Busch S; Brody JS; Rothman PB
Chest; 2002 Mar; 121(3 Suppl):6S-7S. PubMed ID: 11893651
[No Abstract] [Full Text] [Related]
2. The heparan sulfate proteoglycan GPC3 is a potential lung tumor suppressor.
Kim H; Xu GL; Borczuk AC; Busch S; Filmus J; Capurro M; Brody JS; Lange J; D'Armiento JM; Rothman PB; Powell CA
Am J Respir Cell Mol Biol; 2003 Dec; 29(6):694-701. PubMed ID: 12816733
[TBL] [Abstract][Full Text] [Related]
3. Laser capture microdissection and microarray expression analysis of lung adenocarcinoma reveals tobacco smoking- and prognosis-related molecular profiles.
Miura K; Bowman ED; Simon R; Peng AC; Robles AI; Jones RT; Katagiri T; He P; Mizukami H; Charboneau L; Kikuchi T; Liotta LA; Nakamura Y; Harris CC
Cancer Res; 2002 Jun; 62(11):3244-50. PubMed ID: 12036940
[TBL] [Abstract][Full Text] [Related]
4. Genomic and transcriptional alterations in lung adenocarcinoma in relation to smoking history.
Karlsson A; Ringnér M; Lauss M; Botling J; Micke P; Planck M; Staaf J
Clin Cancer Res; 2014 Sep; 20(18):4912-24. PubMed ID: 25037737
[TBL] [Abstract][Full Text] [Related]
5. Chromosomal alterations in lung adenocarcinoma from smokers and nonsmokers.
Sanchez-Cespedes M; Ahrendt SA; Piantadosi S; Rosell R; Monzo M; Wu L; Westra WH; Yang SC; Jen J; Sidransky D
Cancer Res; 2001 Feb; 61(4):1309-13. PubMed ID: 11245426
[TBL] [Abstract][Full Text] [Related]
6. Gene expression in lung adenocarcinomas of smokers and nonsmokers.
Powell CA; Spira A; Derti A; DeLisi C; Liu G; Borczuk A; Busch S; Sahasrabudhe S; Chen Y; Sugarbaker D; Bueno R; Richards WG; Brody JS
Am J Respir Cell Mol Biol; 2003 Aug; 29(2):157-62. PubMed ID: 12600827
[TBL] [Abstract][Full Text] [Related]
7. GPC5, a novel epigenetically silenced tumor suppressor, inhibits tumor growth by suppressing Wnt/β-catenin signaling in lung adenocarcinoma.
Yuan S; Yu Z; Liu Q; Zhang M; Xiang Y; Wu N; Wu L; Hu Z; Xu B; Cai T; Ma X; Zhang Y; Liao C; Wang L; Yang P; Bai L; Li Y
Oncogene; 2016 Nov; 35(47):6120-6131. PubMed ID: 27157618
[TBL] [Abstract][Full Text] [Related]
8. Mutational and epigenetic evidence for independent pathways for lung adenocarcinomas arising in smokers and never smokers.
Toyooka S; Tokumo M; Shigematsu H; Matsuo K; Asano H; Tomii K; Ichihara S; Suzuki M; Aoe M; Date H; Gazdar AF; Shimizu N
Cancer Res; 2006 Feb; 66(3):1371-5. PubMed ID: 16452191
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of invasion and metastasis by glypican-3 in a syngeneic breast cancer model.
Peters MG; Farías E; Colombo L; Filmus J; Puricelli L; Bal de Kier Joffé E
Breast Cancer Res Treat; 2003 Jul; 80(2):221-32. PubMed ID: 12908826
[TBL] [Abstract][Full Text] [Related]
10. Establishment and expression profiling of new lung cancer cell lines from Chinese smokers and lifetime never-smokers.
Lam DC; Girard L; Suen WS; Chung LP; Tin VP; Lam WK; Minna JD; Wong MP
J Thorac Oncol; 2006 Nov; 1(9):932-42. PubMed ID: 17409975
[TBL] [Abstract][Full Text] [Related]
11. Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.
Woenckhaus M; Klein-Hitpass L; Grepmeier U; Merk J; Pfeifer M; Wild P; Bettstetter M; Wuensch P; Blaszyk H; Hartmann A; Hofstaedter F; Dietmaier W
J Pathol; 2006 Oct; 210(2):192-204. PubMed ID: 16915569
[TBL] [Abstract][Full Text] [Related]
12. Glypican-3 expression is silenced in human breast cancer.
Xiang YY; Ladeda V; Filmus J
Oncogene; 2001 Nov; 20(50):7408-12. PubMed ID: 11704870
[TBL] [Abstract][Full Text] [Related]
13. Construction of a 26‑feature gene support vector machine classifier for smoking and non‑smoking lung adenocarcinoma sample classification.
Yang L; Sun L; Wang W; Xu H; Li Y; Zhao JY; Liu DZ; Wang F; Zhang LY
Mol Med Rep; 2018 Feb; 17(2):3005-3013. PubMed ID: 29257283
[TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of the GPC3/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: identification of loss-of-function mutations in the GPC3 gene.
Veugelers M; Cat BD; Muyldermans SY; Reekmans G; Delande N; Frints S; Legius E; Fryns JP; Schrander-Stumpel C; Weidle B; Magdalena N; David G
Hum Mol Genet; 2000 May; 9(9):1321-8. PubMed ID: 10814714
[TBL] [Abstract][Full Text] [Related]
15. Frequent silencing of the GPC3 gene in ovarian cancer cell lines.
Lin H; Huber R; Schlessinger D; Morin PJ
Cancer Res; 1999 Feb; 59(4):807-10. PubMed ID: 10029067
[TBL] [Abstract][Full Text] [Related]
16. Multiplicity of abnormal promoter methylation in lung adenocarcinomas from smokers and never smokers.
Divine KK; Pulling LC; Marron-Terada PG; Liechty KC; Kang T; Schwartz AG; Bocklage TJ; Coons TA; Gilliland FD; Belinsky SA
Int J Cancer; 2005 Apr; 114(3):400-5. PubMed ID: 15578700
[TBL] [Abstract][Full Text] [Related]
17. RNA-seq analysis of lung adenocarcinomas reveals different gene expression profiles between smoking and nonsmoking patients.
Li Y; Xiao X; Ji X; Liu B; Amos CI
Tumour Biol; 2015 Nov; 36(11):8993-9003. PubMed ID: 26081616
[TBL] [Abstract][Full Text] [Related]
18. Mapping of the rat glypican genes.
Szpirer C; Szpirer J; Rivière M; Van Vooren P; Veugelers M; David G
Cytogenet Cell Genet; 2001; 93(1-2):83-6. PubMed ID: 11474185
[TBL] [Abstract][Full Text] [Related]
19. Blocking endogenous glypican-3 expression releases Hep 3B cells from G1 arrest.
Farooq M; Hwang SY; Park MK; Kim JC; Kim MK; Sung YK
Mol Cells; 2003 Jun; 15(3):356-60. PubMed ID: 12872992
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor mutation status is strongly associated with smoking status in patients undergoing surgical resection for lung adenocarcinoma.
Matsumura Y; Owada Y; Inoue T; Watanabe Y; Yamaura T; Fukuhara M; Muto S; Okabe N; Hasegawa T; Hoshino M; Osugi J; Higuchi M; Suzuki H
Interact Cardiovasc Thorac Surg; 2017 Nov; 25(5):690-695. PubMed ID: 29049789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
